| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |